- ICH GCP
- Registre des essais cliniques de l'UE
Derniers essais
EudraCT Number: 2006-005127-42 | Sponsor Protocol Number: APIDR_L_01896 | Start Date: 2006-11-22 | |||||||||||
Sponsor Name: Institut für Klinische Forschung und Entwicklung (ikfe) GmbH | |||||||||||||
Full Title: Effect of Prandial Treatment with Insulin Glulisine compared to Regular Human Insulin on Postprandial Endothelial Function and Microvascular Stress in Type 2 Diabetic Patients | |||||||||||||
Medical condition: Diabetes mellitus Type 2 | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2005-003632-22 | Sponsor Protocol Number: WA19078 | Start Date: 2006-11-22 | ||||||
Sponsor Name: F. Hoffmann-La Roche Ltd. | ||||||||
Full Title: An open-label, exploratory study of the pharmacokinetic and pharmacodynamic activity of rituximab in combination with methotrexate (MTX) in synovial tissue and in peripheral blood of patients with ... | ||||||||
Medical condition: Rheumatoid arthritis | ||||||||
|
||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||
Trial protocol: ES (Completed) | ||||||||
Trial results: View results |
EudraCT Number: 2006-002679-42 | Sponsor Protocol Number: SNT-II-003 | Start Date: 2006-11-22 | ||||||
Sponsor Name: Santhera Pharmaceuticals (Switzerland) Limited | ||||||||
Full Title: A double blind, randomised, placebo-controlled study of the efficacy, safety and tolerability of idebenone in the treatment of patients with Leber's Hereditary Optic Neuropathy | ||||||||
Medical condition: Leber's Hereditary Optic Neuropathy | ||||||||
|
||||||||
Population Age: Adolescents, Under 18, Adults | Gender: Male, Female | |||||||
Trial protocol: GB (Completed) DE (Completed) | ||||||||
Trial results: View results |
EudraCT Number: 2006-000679-14 | Sponsor Protocol Number: Mio/Reg/percutáneo/Aleatorizado | Start Date: 2006-11-22 | |||||||||||
Sponsor Name: INSTITUTO CIENTÍFICO Y TECNOLÓGICO (ICT )DE NAVARRA, S.A. | |||||||||||||
Full Title: ESTUDIO DE FASE II CIEGO, CONTROLADO Y ALEATORIZADO DE EFICACIA DEL IMPLANTE PERCUTÁNEO DE MIOBLASTOS AUTÓLOGOS EN PACIENTES CON INFARTO ANTIGUO. (STUDY PHASE II BLINDED, CONTROLATED AND RANDOMIZED... | |||||||||||||
Medical condition: PACIENTES CON INFARTO ANTIGUO DE MIOCARDIO (PATIENTS WITH OLD MYOCARDIAL INFARCT) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2006-003984-30 | Sponsor Protocol Number: CASM981N2203S | Start Date: 2006-11-22 | |||||||||||
Sponsor Name: Novartis Pharma Services AG | |||||||||||||
Full Title: A multicenter, randomized, double-blind, two-arm, vehicle-controlled, parallel-group, two stage study to evaluate and demonstrate the efficacy and to evaluate the safety of pimecrolimus 1% cream in... | |||||||||||||
Medical condition: Seborrhoeic Dermatitis (SD) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2006-001839-21 | Sponsor Protocol Number: LAP106988 / CHERLOB | Start Date: 2006-11-22 | |||||||||||
Sponsor Name: GLAXO SMITH KLINE | |||||||||||||
Full Title: CHEMOTHERAPY PLUS LAPATINIB OR TRASTUZUMAB OR BOTH IN HER2 PRIMARY BREAST CANCER. A RANDOMIZED PHASE IIb STUDY WITH BIOMARKER EVALUATION. | |||||||||||||
Medical condition: MALIGNANT NEOPLASM FEMALE BREAST | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Female | ||||||||||||
Trial protocol: IT (Completed) GB (Completed) DE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2006-005842-35 | Sponsor Protocol Number: FARM59T23W | Start Date: 2006-11-22 | |||||||||||
Sponsor Name: Dipartimento di Pediatria Universita` di Napoli Federico II | |||||||||||||
Full Title: Efficacy and safety of treatment with N-butyl-deoxynojirimycin (NB-DNJ-miglustat) in patients with Niemann-Pick disease type C. | |||||||||||||
Medical condition: NIEMANN-PICK DISEASE TYPE C | |||||||||||||
|
|||||||||||||
Population Age: Infants and toddlers, Children, Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2006-001990-32 | Sponsor Protocol Number: NOV002-C301 | Start Date: 2006-11-22 | |||||||||||
Sponsor Name: NOVELOS THERAPEUTICS INC. | |||||||||||||
Full Title: A Randomized, Open-Label, Phase 3 Trial of NOV-002 in Combination with Paclitaxel and Carboplatin vs. Paclitaxel and Carboplatin Alone for the Treatment of Advanced Non-Small-Cell Lung Cancer (NS... | |||||||||||||
Medical condition: Patients with advanced NSCLC | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Completed) GB (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2006-002330-38 | Sponsor Protocol Number: RituxiCAN-C4 | Start Date: 2006-11-22 | |||||||||||
Sponsor Name: King's College London | |||||||||||||
Full Title: Randomised Trial of Anti-CD20 in C4d+ Chronic Allograft Nephropathy | |||||||||||||
Medical condition: Renal Transplant Rejection - chronic | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2006-004638-33 | Sponsor Protocol Number: 2006-122 | Start Date: 2006-11-21 | ||||||
Sponsor Name: Department of Orthopedic Surgery, Aarhus University | ||||||||
Full Title: Postoperative pain relief for primary total knee arthroplasty: A randomised clinical trial of local infiltration anaesthesia followed by intraaticulary infusion compared to epidural infusion | ||||||||
Medical condition: Patients with Osteoarthrosis undergoing elective total knee arthroplasty (TKA) | ||||||||
|
||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||
Trial protocol: DK (Prematurely Ended) | ||||||||
Trial results: (No results available) |